UroGen Pharma Ltd. - 8-K Filing
UroGen Pharma Ltd. filed an 8-K on June 23, 2026, reporting results from its Annual Meeting held on June 22, where shareholders approved amendments to the Articles of Association and equity plan. Shareholders voted in favor of amending the Amended and Restated Non-Employee Director and Officer Compensation Policy (26,089,418 votes for) and increasing the share reserve under the 2017 Equity Incentive Plan by 1 million shares (25,204,644 votes for). The Annual Meeting also elected seven directors with over 83% of votes in favor across all nominees. (Items: 3.03 Material Modification to Rights of Security Holders, 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 5.07 Submission of Matters to a Vote of Security Holders, 9.01 Financial Statements and Exhibits)
Tickers: $URGN